Confirm delete?

Bertin Bioreagent
logo

Search

Contact Us

CAY10509

  • Zoom
    CAY10509
  • CAY10509
Cat No: 10009167
Chemicals - Miscellaneous Chemicals
Cayman
€32.00
Price is excluding VAT and does not include packaging neither shipping

Derivative of PGF1α containing a thio-fluorobenzene substituent in the lower side chain; binds to the recombinant human FP receptor with an IC50 value of about 30 nM
The actions of many clinical prostaglandins, including those used for estrous synchron...

More

This product can only be bought through Cayman Chemical. Please contact us.

- +
Territorial Availability: Available through Bertin Technologies only in Europe
Product Overview:
Derivative of PGF1α containing a thio-fluorobenzene substituent in the lower side chain; binds to the recombinant human FP receptor with an IC50 value of about 30 nM
The actions of many clinical prostaglandins, including those used for estrous synchronization and for reduction of intraocular pressure, are mediated through the FP receptor. CAY10509 is an analog of PGF2α containing a thio-fluorobenzene substituent in the lower side chain. CAY10509 has an IC50 of about 30 nM when tested for binding to the recombinant human FP receptor.
Size: 100 µg
Shipping: wet ice
Stability: Store at -20 degrees; shelf life 365 days maximum after production
CAS Number: 1245699-47-1
Molecular Formula: C23H35FO5S
SMILES: O[C@@H]1C[C@H](O)[C@H](CCCCCCC(OC)=O)[C@H]1CC[C@@H](O)CSC2=C(F)C=CC=C2
Molecular Weight: 442.6
Formulation: A solution in ethyl acetate
Purity: ≥98%
Custom Code: 2937500000
UNSPSC code: 12352100
UN Number: UN1173

Cayman Chemical's mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.

Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.

Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.

Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.

Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009

Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.

/ We also advise you

Cross selling for this product : CAY10509 There are 4 products.